Month: June 2021

BREXAFEMME® (ibrexafungerp tablets), for oral useA novel oral antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known as vaginal yeast infectionBREXAFEMME to receive 5-year exclusivity extension under the GAIN Act for a total of 10 years of regulatory exclusivity BREXAFEMME also protected by composition-of-matter patent until 2035 Commercial launch update call is scheduled for Tuesday, June 29th @ 12pm ETJERSEY CITY, N.J., June 09, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced that the U.S. Food and Drug Administration (FDA) granted BREXAFEMME (ibrexafungerp tablets), five years of exclusivity extension under the Generating...

ROUYN-NORANDA, Québec, June 09, 2021 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, L&S Exchange, TTM Zone, Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to inform shareholders that it has sold the McNeely Lithium project consisting of 66 mining claims in La Corne, Landrienne and Figuery townships, Quebec to First Energy Metals Limited (FE-CSE). The claims have been sold for a single cash payment of $250,000 and 2,000,000 First Energy Metals shares (currently $0.30 a share). Globex will retain a 3% Gross Metal Royalty on all production from the claims. Globex’s McNeely claims extend westward from the Quebec Lithium Mine property intermittently in several claim blocks over a strike length of...

ATLANTA, June 09, 2021 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus” or the “Company”) today announced the pricing of its underwritten registered public offering of 2,800,000 shares of 7.625% Series B Cumulative Perpetual Preferred Stock, no par value and liquidation preference of $25.00 per share (the “Preferred Stock”) at an initial public offering price of $25.00 per share, raising gross proceeds of $70 million before deducting underwriting discounts, the structuring fee and other estimated offering expenses. In connection with the offering, the Company has granted the underwriters a 30-day option to purchase up to an additional 420,000 shares of Preferred Stock. The offering is expected to close on or about June 11, 2021, subject to customary closing conditions. The Company’s shares of Preferred...

Los Angeles, CA, June 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — On June 4, 2021, US Nuclear (OTCQB: UCLE) signed an agreement to take a 5% stake in Solar System Resources Corporation Sp. z o. o., thus advancing US Nuclear’s portfolio of high-tech startups.  US Nuclear and Solar System Resources decided to keep the details of the transaction private.     Solar System Resources is a space mining company that conducts localization, in-situ verification, and mining of space resources.  US Nuclear will cooperate with Solar System Resources and other partners to build a value chain starting with mining and selling valuable helium-3, lanthanide metals, and other vital or precious materials from space deposits.  This is just the latest investment of US Nuclear, which can be viewed as a holding company and incubator with stakes...

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it is initiating immediate availability of Triamcinolone Hexacetonide Injectable Suspension, USP (20 mg/ml) (TH) in the United States via the U.S. Food and Drug Administration’s (FDA) CDER Drug Shortage program. More information about the FDA’s Drug Shortage program is available at: FDA Drug Shortages. TH is indicated for intra-articular, intrasynovial, or periarticular use in adults and adolescents for the symptomatic treatment of subacute and chronic inflammatory joint diseases, including: rheumatoid arthritis, juvenile idiopathic arthritis (JIA), osteoarthritis and post-traumatic arthritis, synovitis, tendinitis, bursitis and epicondylitis. To...

NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) — XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced that the Company is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution according to a preliminary list of additions posted on June 4. Joining the index would become effective after the US market opens on June 28. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. Doug Satzman, CEO of XpresSpa Group, said, “We view inclusion in the Russell Microcap Index is an important company milestone...

CORONA, Calif., June 09, 2021 (GLOBE NEWSWIRE) — Advanced Container Technologies, Inc (Ticker: ACTX), announced that Grassfire Distro – its exclusive distributor for Oklahoma, launched several new products and services, and finalized a number of important deals at this year’s CannaCon Conference in the Oklahoma City. ACTX has an array of products and services designed to help legal cannabis dispensaries improve revenues and enhance customer loyalty. The company selected Grassfire Distro to represent its products in Oklahoma due to Grassfire’s local market knowledge, established relationships, and “boots on the ground.” Oklahoma is now the biggest medical marijuana market in the country on a per capita basis, according to a report in Politico. Additionally, an annual jobs report shows that the legal cannabis industry in Oklahoma...

TORONTO, June 09, 2021 (GLOBE NEWSWIRE) — Unisync Corp. (“Unisync“) (TSX:”UNI”) (OTCQX:“USYNF”) is pleased to announce that it has been selected by BC Ferries to manage their employee uniform program. This multi-year agreement represents the culmination of an extensive review of Unisync’s award-winning product quality and customer-focused suite of fulfillment services. The agreement covers the sourcing, supply and program management of operational clothing for all of BC Ferries uniformed staff. “We are pleased and honoured to have been selected by BC Ferries to be their uniform provider,” commented CEO, Matthew Graham. “BC Ferries is an iconic transit provider in the province of British Columbia and provides a lifeline to remote and coastal communities in British Columbia. We will be working to ensure that every...

SAN FRANCISCO, June 09, 2021 (GLOBE NEWSWIRE) — Opendoor Technologies Inc. (Nasdaq: OPEN), (“Opendoor” or “the Company”), a leading digital platform for residential real estate, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), that were issued under the Warrant Agreement, dated April 27, 2020, by and between the Company and Continental Stock Transfer & Trust Company (“CST”), as warrant agent, as amended by the First Amendment to the Warrant Agreement, dated March 22, 2021, by and among the Company, CST and American Stock Transfer & Trust Company (the “Warrant Agent”), as warrant agent (as amended, the “Warrant Agreement”), as part of the units sold in the Company’s initial...

WARREN, N.J., June 09, 2021 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that the management team will participate in two upcoming investor conferences in June. The Aquestive team is scheduled to hold a fireside chat at the JMP Securities 2021 Life Sciences Conference on Wednesday, June 16 at 2:30 pm ET. The Aquestive team will participate in a rare disease panel at BMO Capital Market 2021 Biopharma Day: Spotlight on Rare Disease and Ophthalmology at 10:15 am ET on Tuesday, June 22. Aquestive will host investor meetings throughout both conferences. The webcast of the fireside chat will be available on the “Events and Presentation”...